Clinical trial / 1994
Results suggest ovomucoid is the immunodominant egg white protein and that ovalbumin's allergenicity may have been overestimated.
Mice were injected with commercially purified or HPLC-repurified ovalbumin, showing antibody responses to commercial ovalbumin were largely directed against minor (< 1%) ovomucoid contamination. In 18 children with egg allergy, skin prick wheal diameters were significantly greater for DEAE-repurified ovomucoid than ovalbumin, lysozyme, and egg white extract at concentrations of 0.01, 0.03, and 0.1 mg/ml (p < 0.01). Serum ovomucoid-specific IgE and IgG levels were also significantly greater than those to ovalbumin (p < 0.05). Furthermore, in 10 patients with persistent hypersensitivity versus 11 who developed tolerance, IgE to repurified ovomucoid was significantly higher at initial and follow-up challenges, with no differences observed for ovalbumin IgE.
- Study type
- Experimental animal study and human comparative testing
- Who was studied
- 18 children with egg allergy, plus 10 patients with persistent egg hypersensitivity and 11 who developed clinical tolerance, alongside mice
- What was measured
- Antibody specificity in mice; skin prick test wheal diameter and serum IgE/IgG concentrations in humans
THE PAPER
Allergenicity and antigenicity of chicken egg ovomucoid (Gal d III) compared with ovalbumin (Gal d I) in children with egg allergy and in mice.
Bernhisel-Broadbent J, Dintzis HM, Dintzis RZ, Sampson HA. J Allergy Clin Immunol, 1994.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.